Monoclonal antibodies inhibit prion replication and delay the development of prion disease

Nature

Volumn 422, Issue 6927, 2003, Pages 80-83

  White, Anthony R ^a   Enever, Perry ^a   Tayebi, Mourad ^a   Mushens, Rosey ^b   Linehan, Jackie ^c   Brandner, Sebastian ^c   Anstee, David ^b   Collinge, John ^a,c   Hawke, Simon ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; IMMUNOLOGY; NEUROLOGY;

NEURO-DEGENERATIVE DISORDERS;

MONOCLONAL ANTIBODIES;

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; MONOCLONAL ANTIBODY; PRION PROTEIN MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY; CREUTZFELDT JAKOB DISEASE; PRION DISEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRION; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE; SPLEEN; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOHISTOCHEMISTRY; MICE; PRION DISEASES; PRPSC PROTEINS; SCRAPIE; SURVIVAL RATE;

ANIMALIA; BOVINAE; MURINAE;

EID: 0037422133     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature01457     Document Type: Article

References (30)

1. Collinge, J., Sidle, K. C., Meads, J., Ironside, J. & Hill, A. F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383, 685-690 (1996).
2. Bruce, M. E. et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389, 498-501 (1997).
3. Hill, A. F. et al. The same prion strain causes vCJD and BSE. Nature 389, 448-450 (1997).
4. Will, R. G. et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925 (1996).
5. Prusiner, S. B. Prions. Proc. Natl Acad. Sci. USA 95, 13363-13383 (1998).
6. Enari, M., Flechsig, E. & Weissmann, C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. USA 98, 9295-9299 (2001).
7. Peretz, D. et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739-743 (2001).
8. Jackson, G. S. et al. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283, 1935-1937 (1999).
9. Jackson, G. S. et al. Multiple folding pathways for heterologously expressed human prion protein. Biochim. Biophys. Acta 1431, 1-13 (1999).
10. Bueler, H. et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582 (1992).
11. Beringue, V. et al. Regional heterogeneity of cellular prion protein isoforms in the brain. Brain (submitted).
12. Beringue, V. et al. Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent. J. Virol. 74, 5432-5440 (2000).
13. Souan, L. et al. Modulation of proteinase-K resistant prion protein by prion peptide immunisation. Eur. J. Immunol. 31, 2338-2346 (2001).
14. Heppner, F. L. et al. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294, 178-182 (2001).
15. Westaway, D. & Carlson, G. A. Mammalian prion proteins: enigma, variation and vaccination. Trends Biochem. Sci. 27, 301-307 (2002).
16. Klein, M. A. et al. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nature Med. 4, 1429-1433 (1998).
17. Montrasio, F. et al. Impaired prion replication in spleens ofmice lacking functional follicular dendritic cells. Science 288, 1257-1259 (2000).
18. Brown, K. L. et al. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nature Med. 5, 1308-1312 (1999).
19. McKenzie, D., Kaczkowsli, J., Marsh, R. & Aiken, J. Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection. J. Virol. 68, 7534-7536 (1994).
20. Ingrosso, L., Ladogana, A. & Pocchiari, M. Congo red prolongs the incubation period in scrapie-infected hamsters. J. Virol. 69, 506-508 (1995).
21. Farquhar, C., Dickinson, A. & Bruce, M. Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies. Lancet 353, 117 (1999).
22. Brown, P. Drug therapy in human and experimental transmissible spongiform encephalopathy. Neurology 58, 1720-1725 (2002).
23. Sethi, S., Lipford, G., Wagner, H. & Kretzschmar, H. Postexposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet 360, 229-230 (2002).
24. Sigurdsson, E. M. et al. Immunisation delays the onset of prion disease in mice. Am. J. Pathol. 161, 13-17 (2002).
25. Bard, F. et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Med. 6, 916-919 (2000).
26. Brandner, S. et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343 (1996).
27. Anstee, D. J. et al. New monoclonal antibodies in CD44 and CD58: their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution ofCD44 and CD58 in human tissues. Immunology 74, 197-205 (1991).
28. Avent, N. D. et al. Protein-sequence studies on Rh-related polypeptides suggest the presence of at least two groups of proteins which associate in the human red-cell membrane. Biochem. J. 256, 1043-1046 (1988).
29. Dickinson, A. G., Meikle, V. M. & Fraser, H. Identification of a gene which controls the incubation period ofsome strains of scrapie agent in mice. J. Comp. Pathol. 78, 293-299 (1968).
30. Wadsworth, J. D. et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358, 171-180 (2001).